Showing results (331-340 of 644) with videos related to

Sort By:
Pageof 65
Research Square|February 17, 2023
ApoE Alzheimer's Disease Aβ-amyloid plaque morphology varies according to APOE isotypeIna Caesar, K Peter R Nilsson, Per Hammarstrom, et al.
Science (New York, N.Y.)|May 25, 2013
Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models"Karthikeyan Veeraraghavalu, Can Zhang, Sean Miller, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 16, 2017
Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 yearsSuzanne E Schindler, Courtney L Sutphen, Charlotte Teunissen, et al.
Neurobiology of Aging|May 9, 2017
Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer diseaseSuzanne E Schindler, Mateusz S Jasielec, Hua Weng, et al.
Multiple Sclerosis and Related Disorders|August 5, 2026
Clinical features of older MS patients with and without Alzheimer disease biomarkersApollo Rodriguez, Bradley Judge, Nicole Shelley, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2011
Nicotinamide mononucleotide adenylyl transferase 1 protects against acute neurodegeneration in developing CNS by inhibiting excitotoxic-necrotic cell deathPhilip B Verghese, Yo Sasaki, Donghan Yang, et al.
Life Science Alliance|August 10, 2023
Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegenerationAntoine Drieu, Siling Du, Michal Kipnis, et al.
Annals of Neurology|May 1, 2016
Obstructive sleep apnea decreases central nervous system-derived proteins in the cerebrospinal fluidYo-El S Ju, Mary Beth Finn, Courtney L Sutphen, et al.
Neurosurgery|August 30, 2016
Lumbar Cerebrospinal Fluid Biomarkers of Posthemorrhagic Hydrocephalus of Prematurity: Amyloid Precursor Protein, Soluble Amyloid Precursor Protein α, and L1 Cell Adhesion MoleculeDiego M Morales, Shawgi A Silver, Clinton D Morgan, et al.
The American Journal of Pathology|August 28, 2004
A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic miceMarcin Sadowski, Joanna Pankiewicz, Henrieta Scholtzova, et al.
Pageof 65